Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna Inc.

Insiders have been trading these 5 stocks: (($JPM)), (($CVX)), (($MSTR)), (($MRNA)) and (($SNAP)). Here is a breakdown of their recent trades and t...

JPMorgan, Chevron, Strategy, Moderna, Snap Insider Shake-Up

In a report released today, Alec Stranahan from Bank of America Securities maintained a Sell rating on Moderna, with a price target of $32.00. Acco...

Bank of America Securities Sticks to Its Sell Rating for Moderna (MRNA)

Moderna ( ($MRNA) ) has fallen by -7.26%. Read on to learn why. Moderna’s share price slipped 7.26% over the past week, as investors weighed headli...

Moderna Stock Stumbles as Vaccine Hype Meets Reality

Moderna ($MRNA) announced an update on their ongoing clinical study. Moderna and Merck Advance Personalized Lung Cancer Vaccine Trial The Phase 3 s...

Moderna and Merck Push Personalized Lung Cancer Vaccine Into Phase 3

The SPDR S&P 500 ETF Trust ($SPY) rose 0.56% today, May 13, as a strong rebound in AI and semiconductor stocks outweighed hotter-than-expected infl...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/13/2026

Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $45.00. The company’s shares closed yester...

Bernstein Reaffirms Their Hold Rating on Moderna (MRNA)

U.S. pharma and biotech firm Moderna’s ($MRNA) shares climbed by about 9% in Monday’s pre-market session, extending their roughly 12% gain on Frida...

Moderna Stock (MRNA) Extends Breakout amid Hantavirus Fears

Moderna ( ($MRNA) ) has risen by 14.90%. Read on to learn why. Moderna shares climbed 14.90% over the past week as investors rushed into the stock ...

Moderna’s Hantavirus Hype Fuels Rally Amid Setbacks

The SPDR S&P 500 ETF Trust ($SPY) gained 0.83% today, May 8, at a record high. The ETF was lifted by strong gains in AI‑focused tech stocks and a b...

Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 5/8/2026?

The SPDR S&P 500 ETF Trust ($SPY) fell 0.31% today, May 7, pulling back from record highs as investors took profits. Renewed uncertainty around U.S...

Why Is SPDR S&P 500 ETF Trust (SPY) Down Today, 5/7/2026?

In a report released yesterday, from Berenberg Bank maintained a Hold rating on Moderna, with a price target of $45.00. In addition to Berenberg Ba...

Berenberg Bank Sticks to Its Hold Rating for Moderna (MRNA)

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), gained 0.50% in Tuesday’s pre-market trading as solid corporate earnings and...

Why Is Vanguard S&P 500 ETF (VOO) Up Today, 5/5/2026?

The SPDR S&P 500 ETF Trust ($SPY) slipped 0.37% today, May 4, pulling back from record highs as rising tensions in the Middle East, particularly ar...

Why Is SPDR S&P 500 ETF Trust (SPY) Down Today, 5/4/2026?

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), slipped 0.05% in Monday’s pre-market trading as new developments in the Midd...

Why Is Vanguard S&P 500 ETF (VOO) Sliding Today, 5/4/2026?

Barclays analyst Eliana Merle maintained a Hold rating on Moderna today and set a price target of $48.00. According to TipRanks, Merle is a 3-star ...

Barclays Sticks to Their Hold Rating for Moderna (MRNA)

Moderna (($MRNA)) has held its Q1 earnings call. Read on for the main highlights of the call. Moderna’s latest earnings call struck a cautiously op...

Moderna Earnings Call: Revenue Rebound, Legal Overhang

The SPDR S&P 500 ETF Trust ($SPY) gained 0.28% today, May 1, reaching a new record high. The upside was driven by strong quarterly earnings from Ap...

Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 5/1/2026?

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Moderna (MRNA) and Stryker (SYK). Moderna (MRNA) In a report rele...

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Stryker (SYK)

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), rose 0.30% in Friday’s pre-market trading, led by a 3% jump in Apple ($AAPL)...

Why Is Vanguard S&P 500 ETF (VOO) Up Today, 5/1/2026?

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merit Medical Systems (MMSI), Alterity Therapeutics (ATHE) and Mo...

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Alterity Therapeutics (ATHE) and Moderna (MRNA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (ILMN), Moderna (MRNA) and Dexcom (DXCM). Illumina (ILMN...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), Moderna (MRNA) and Dexcom (DXCM)

The SPDR S&P 500 ETF Trust ($SPY) gained 0.96% today, April 30. Positive earnings reports from some major companies, including Alphabet ($GOOGL), h...

Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 4/30/2026?

On Friday, May 1, Chevron ($CVX), Exxon Mobil ($XOM), and Moderna ($MRNA) will report their earnings. All three companies will report before the ma...

Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow?

The SPDR S&P 500 ETF Trust ($SPY) declined 0.02% today, April 29, as investors weighed big earnings reports, rising energy prices from geopolitical...

Why Is the SPY ETF Down Today, 4/29/2026?

The SPDR S&P 500 ETF Trust ($SPY) gained 0.17% today, April 27, lifted by ongoing optimism about AI stocks, anticipation of major tech earnings, an...

Why Is the SPY ETF Up Today, 4/27/2026?

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), slipped 0.04% in pre-market trading on Monday amid stalled talks between the...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRNA	$47.37	+1.05%	1.84M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRNA	$47.37	+1.0%	1.84M
3
4
5
6

MRNA

MRNA

Get Moderna Inc. Data in Excel

Get Moderna Inc. Data in Excel